Literature DB >> 20147321

Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.

Juliane S Müller1, Catherine D Jepson, Steven H Laval, Kate Bushby, Volker Straub, Hanns Lochmüller.   

Abstract

The small signalling adaptor protein Dok-7 has recently been reported as an essential protein of the neuromuscular junction (NMJ). Mutations resulting in partial loss of Dok-7 activity cause a distinct limb-girdle subtype of the inherited NMJ disorder congenital myasthenic syndromes (CMSs), whereas complete loss of Dok-7 results in a lethal phenotype in both mice and humans. Here we describe the zebrafish orthologue of Dok-7 and study its in vivo function. Dok-7 deficiency leads to motility defects in zebrafish embryos and larvae. The relative importance of Dok-7 at different stages of NMJ development varies; it is crucial for the earliest step, the formation of acetylcholine receptor (AChR) clusters in the middle of the muscle fibre prior to motor neuron contact. At later stages, presence of Dok-7 is not absolutely essential, as focal and non-focal synapses do form when Dok-7 expression is downregulated. These contacts however are smaller than in the wild-type zebrafish, reminiscent of the neuromuscular endplate pathology seen in patients with DOK7 mutations. Intriguingly, we also observed changes in slow muscle fibre arrangement; previously, Dok-7 has not been linked to functions other than postsynaptic AChR clustering. Our results suggest an additional role of Dok-7 in muscle. This role seems to be independent of the muscle-specific tyrosine kinase MuSK, the known binding partner of Dok-7 at the NMJ. Our findings in the zebrafish model contribute to a better understanding of the signalling pathways at the NMJ and the pathomechanisms of DOK7 CMSs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147321     DOI: 10.1093/hmg/ddq049

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.

Authors:  Jan Senderek; Juliane S Müller; Marina Dusl; Tim M Strom; Velina Guergueltcheva; Irmgard Diepolder; Steven H Laval; Susan Maxwell; Judy Cossins; Sabine Krause; Nuria Muelas; Juan J Vilchez; Jaume Colomer; Cecilia Jimenez Mallebrera; Andres Nascimento; Shahriar Nafissi; Ariana Kariminejad; Yalda Nilipour; Bita Bozorgmehr; Hossein Najmabadi; Carmelo Rodolico; Jörn P Sieb; Ortrud K Steinlein; Beate Schlotter; Benedikt Schoser; Janbernd Kirschner; Ralf Herrmann; Thomas Voit; Anders Oldfors; Christopher Lindbergh; Andoni Urtizberea; Maja von der Hagen; Angela Hübner; Jacqueline Palace; Kate Bushby; Volker Straub; David Beeson; Angela Abicht; Hanns Lochmüller
Journal:  Am J Hum Genet       Date:  2011-02-11       Impact factor: 11.025

2.  The cellular and molecular progression of mitochondrial dysfunction induced by 2,4-dinitrophenol in developing zebrafish embryos.

Authors:  Jennifer E Bestman; Krista D Stackley; Jennifer J Rahn; Tucker J Williamson; Sherine S L Chan
Journal:  Differentiation       Date:  2015-03-12       Impact factor: 3.880

3.  Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.

Authors:  Nikos Malissovas; Laurie B Griffin; Anthony Antonellis; Dimitris Beis
Journal:  Hum Mol Genet       Date:  2016-02-07       Impact factor: 6.150

4.  The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes.

Authors:  Grace McMacken; Dan Cox; Andreas Roos; Juliane Müller; Roger Whittaker; Hanns Lochmüller
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

5.  MYO9A deficiency in motor neurons is associated with reduced neuromuscular agrin secretion.

Authors:  Emily O'Connor; Vietxuan Phan; Isabell Cordts; George Cairns; Stefan Hettwer; Daniel Cox; Hanns Lochmüller; Andreas Roos
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

Review 6.  Neuromuscular disorders in zebrafish: state of the art and future perspectives.

Authors:  Andrea Pappalardo; Letizia Pitto; Chiara Fiorillo; M Alice Donati; Claudio Bruno; Filippo M Santorelli
Journal:  Neuromolecular Med       Date:  2013-04-13       Impact factor: 3.843

7.  Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness.

Authors:  Teresinha Evangelista; Mike Hanna; Hanns Lochmüller
Journal:  J Neuromuscul Dis       Date:  2015-07-22

8.  Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.

Authors:  Amina Chaouch; Vito Porcelli; Daniel Cox; Shimon Edvardson; Pasquale Scarcia; Anna De Grassi; Ciro L Pierri; Judith Cossins; Steven H Laval; Helen Griffin; Juliane S Müller; Teresinha Evangelista; Ana Töpf; Angela Abicht; Angela Huebner; Maja von der Hagen; Kate Bushby; Volker Straub; Rita Horvath; Orly Elpeleg; Jacqueline Palace; Jan Senderek; David Beeson; Luigi Palmieri; Hanns Lochmüller
Journal:  J Neuromuscul Dis       Date:  2014

9.  Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome.

Authors:  Emily O'Connor; Ana Töpf; Juliane S Müller; Daniel Cox; Teresinha Evangelista; Jaume Colomer; Angela Abicht; Jan Senderek; Oswald Hasselmann; Ahmet Yaramis; Steven H Laval; Hanns Lochmüller
Journal:  Brain       Date:  2016-06-03       Impact factor: 13.501

10.  Altered RNA metabolism due to a homozygous RBM7 mutation in a patient with spinal motor neuropathy.

Authors:  Michele Giunta; Shimon Edvardson; Yaobo Xu; Markus Schuelke; Aurora Gomez-Duran; Veronika Boczonadi; Orly Elpeleg; Juliane S Müller; Rita Horvath
Journal:  Hum Mol Genet       Date:  2016-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.